Table 2.

Clinical features at presentation of the CLL cohorts^*

DOI: http://dx.doi.org/10.7554/eLife.02869.018

	TEDG analysis			SA analysis
	N	Total	%	N	Total	%
IGHV homology >98%	37	69	53.6	532	1380	38.6
del13q14	35	70	50.0	682	1403	48.6
+12	19	70	27.1	205	1403	14.6
del11q22-q23	8	70	11.4	136	1403	9.7
del17p13	20	70	28.6	114	1403	8.1
TP53 mutation	22	70	31.4	114	1401	8.1
NOTCH1 mutation	22	70	31.4	150	1403	10.7
SF3B1 mutation	17	70	24.3	100	1403	7.1
MYD88 mutation	6	70	8.6	52	1403	3.7
BIRC3 mutation	10	70	14.3	41	1403	2.9
BIRC3 deletion	6	70	8.6	79	1403	5.6

^*TEDG analysis, Tumor Evolutionary Directed Graphs analysis; SA analysis, Statistical Association analysis; IGHV, immunoglobulin heavy variable gene; FISH, fluorescence in situ hybridization.